BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
CPSS
Consumer Portfolio Services, Inc.
There isn't enough reported data to score CPSS yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CPSS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CPSS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CPSS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CPSS in the historical PE scenario, which offers more potential upside but is not a forecast.
CPSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4x | $4.08 | -58% |
| Fair | 6.3x | $6.44 | -34% |
| Current | 9.6x | $9.77 | — |
| Expensive | 11x | $10.91 | +12% |
Historical ranges are pointers, not guarantees.
CPSS's PE is 9.6x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CPSS Forward outlook
There aren't enough analyst estimates for CPSS to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CPSS on earnings, with more consistent year-over-year improvement.
CPSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.02 | +27% |
| Q2 2026 | $0.92 | +15% |
| Q1 2026 | $0.85 | +7.6% |
| Q4 2025 | $0.80 | +1.3% |
| Q3 2025 | $0.80 | -9.1% |
| Q2 2025 | $0.80 | -27% |
| Q1 2025 | $0.79 | -46% |
| Q4 2024 | $0.79 | -56% |
CPSS's earnings per share have fallen from their peak: $1.02 over the past year, against $3.33 in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over CPSS on profitability, with a higher operating margin.
CPSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $131.9M | +22% |
| Q2 2026 | $121.4M | +11% |
| Q1 2026 | $112.3M | +5.1% |
| Q4 2025 | $109.4M | +3.9% |
| Q3 2025 | $108.4M | +7.8% |
| Q2 2025 | $109.8M | +14% |
| Q1 2025 | $106.9M | +16% |
| Q4 2024 | $105.3M | +14% |
CPSS has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +1.1 points |
| Q2 2026 | 7.4% | +1.1 points |
| Q1 2026 | 7.2% | +0.8 points |
| Q4 2025 | 6.6% | -0.4 points |
| Q3 2025 | 6.5% | -0.3 points |
| Q2 2025 | 6.3% | -0.6 points |
| Q1 2025 | 6.4% | -0.8 points |
| Q4 2024 | 7% | -3.7 points |
CPSS's operating margin was 7.6% last quarter, up 1.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
CPSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94.2M | +11% |
| Q2 2026 | $105.9M | +95% |
| Q1 2026 | $83M | +13% |
| Q4 2025 | $75.7M | +11% |
| Q3 2025 | $84.9M | +22% |
| Q2 2025 | $54.3M | +26% |
| Q1 2025 | $73.4M | +40% |
| Q4 2024 | $67.9M | +22% |
CPSS has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CPSS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CPSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -165K shares |
| 1 year | -3% | -726K shares |
| 3 years | -7.5% | -1.9M shares |
| 5 years | -2.3% | -559K shares |
CPSS has 23M diluted shares, down 3% from a year ago, with $11M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.2M |
| Q2 2026 | $2.5M |
| Q1 2026 | $1.2M |
| Q4 2025 | $2.6M |
| Q3 2025 | $981,000 |
| Q2 2025 | $5.1M |
| Q1 2025 | — |
| Q4 2024 | — |
CPSS spent $11M buying back its own shares over the past year, up 86% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over CPSS on leverage, with a lower net debt burden relative to earnings.
CPSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 118.9x | High |
| Q2 2026 | 119.1x | High |
| Q1 2026 | 115.7x | High |
| Q4 2025 | 115.4x | High |
| Q3 2025 | 112.6x | High |
| Q2 2025 | 111.2x | High |
| Q1 2025 | 108.4x | High |
| Q4 2024 | 107.5x | High |
CPSS's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CPSS.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CPSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 88.7 | Overbought |
CPSS's weekly RSI is 55 (neutral) and its Stochastic is 89 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
CPSS PE vs Financial Services Sector
| Metric | CPSS | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 13x | 26% below |
| PE % | 72 | 63 | 9 pts above |
CPSS has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CPSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.64 | 1.3% above |
| 20 week MA | $9.49 | 3% above |
| 50 week MA | $9.12 | 7.1% above |
| 100 week MA | $9.15 | 6.8% above |
| 200 week MA | $9.42 | 3.7% above |
CPSS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CPSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.37 | $4.24 | +26% |
| 2021 | $4.24 | $8.94 | +111% |
| 2022 | $8.94 | $8.53 | -4.6% |
| 2023 | $8.53 | $9.37 | +9.8% |
| 2024 | $9.37 | $10.5 | +12% |
| 2025 | $10.5 | $9.13 | -13% |
| 2026 YTD | $9.13 | $9.77 | +7% |
CPSS has the edge over BAC on returns for 2026, with the stronger performance.